These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15488029)

  • 21. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
    Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
    Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APC mutations in sporadic medulloblastomas.
    Huang H; Mahler-Araujo BM; Sankila A; Chimelli L; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 2000 Feb; 156(2):433-7. PubMed ID: 10666372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
    Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
    Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age.
    Brugières L; Remenieras A; Pierron G; Varlet P; Forget S; Byrde V; Bombled J; Puget S; Caron O; Dufour C; Delattre O; Bressac-de Paillerets B; Grill J
    J Clin Oncol; 2012 Jun; 30(17):2087-93. PubMed ID: 22508808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular abnormalities in pediatric embryonal brain tumors--analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22.
    Zakrzewska M; Rieske P; Debiec-Rychter M; Zakrzewski K; Polis L; Fiks T; Liberski PP
    Clin Neuropathol; 2004; 23(5):209-17. PubMed ID: 15581023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours.
    Thiel G; Marczinek K; Neumann R; Witkowski R; Marchuk DA; Nurnberg P
    Anticancer Res; 1995; 15(6B):2495-9. PubMed ID: 8669813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of survivin splice isoforms in medulloblastomas.
    Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas.
    Su TH; Chang JG; Yeh KT; Lin TH; Lee TP; Chen JC; Lin CC
    Oncol Rep; 2003; 10(5):1195-200. PubMed ID: 12883680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
    Mueller W; Lass U; Wellmann S; Kunitz F; von Deimling A
    Acta Neuropathol; 2005 Mar; 109(3):314-20. PubMed ID: 15668788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis.
    Zhou CX; Gao Y
    Oncol Rep; 2007 Jan; 17(1):73-9. PubMed ID: 17143481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
    Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
    Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational screening of the APC gene in Chilean families with familial adenomatous polyposis: nine novel truncating mutations.
    De la Fuente MK; Alvarez KP; Letelier AJ; Bellolio F; Acuña ML; León FS; Pinto E; Carvallo P; López-Köstner F
    Dis Colon Rectum; 2007 Dec; 50(12):2142-8. PubMed ID: 17963004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
    Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
    J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
    Schüller U; Koch A; Hartmann W; Garrè ML; Goodyer CG; Cama A; Sörensen N; Wiestler OD; Pietsch T
    Int J Cancer; 2005 Oct; 117(1):82-9. PubMed ID: 15880586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients.
    Hama S; Matsuura S; Tauchi H; Sawada J; Kato C; Yamasaki F; Yoshioka H; Sugiyama K; Arita K; Kurisu K; Kamada N; Heike Y; Komatsu K
    Anticancer Res; 2000; 20(3B):1897-900. PubMed ID: 10928123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors.
    Franco-Hernandez C; Martinez-Glez V; Arjona D; de Campos JM; Isla A; Gutierrez M; Vaquero J; Rey JA
    Cancer Genet Cytogenet; 2007 Feb; 173(1):63-7. PubMed ID: 17284372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis of ETV6 in prostate carcinoma.
    Kibel AS; Faith DA; Bova GS; Isaacs WB
    Prostate; 2002 Sep; 52(4):305-10. PubMed ID: 12210491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP53, β-Catenin and c-myc/N-myc status in embryonal tumours with ependymoblastic rosettes.
    Gessi M; Zur Muehlen A; Lauriola L; Gardiman MP; Giangaspero F; Pietsch T
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):406-13. PubMed ID: 21073496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.